EULAR 2010 Conference Review - Reviewed by Dr Hedley Griffiths

In this review:

MRI shows early effects of tocilizumab
Tocilizumab in previous DMARD- and TNF-failure patients
Tocilizumab in systemic juvenile idiopathic arthritis
Rituximab inhibits joint damage
Higher rituximab dose achieves clinical response
Rituximab treat to target

Please login below to download this issue (PDF)

Subscribe